Rennova Health Adds Electronic Medication Administration Record to M2Select Electronic Health Record Product

Download as PDF

WEST PALM BEACH, Fla.-- Rennova Health Inc. (NASDAQ:RNVA) (NASDAQ:RNVAW) announces that its wholly owned electronic health records software developer Medical Mime, Inc. has added electronic medication management software to its flagship M2Select electronic health record (EHR) product. Launched in the fourth quarter of 2015, M2Select is sold to substance abuse treatment and behavioral health providers.

Electronic Medication Administration Record, or eMAR, is designed to replace paper-based medicine tracking and reconciliation. This integrated solution makes it possible for substance abuse centers and facilities to improve efficiencies by eliminating a number of paper-centric processes. eMAR clearly and simply informs physicians of all medications to be given to a patient in an organized manner, thus improving communication between facility staff and the pharmacy, and reducing the risk of medication dispensing errors. Simply put, eMAR automates everything – gathering, consolidating and presenting data with more speed and accuracy than any manual system. eMAR also saves time and money, and allows for better traceability and access to historical records, which ultimately creates a higher standard of care for resident patients.

“The ability to offer this eMAR function in our EHR software takes us a step closer to achieving our goal of providing a fully integrated practice management solution. In addition to efficiency and compliance benefits, eMAR provides our customers with the necessary tools to achieve certain accreditations that are now required by payers,” said Seamus Lagan, CEO of Rennova. “We are already seeing benefits to our growth strategy, with customers electing to integrate this software product and our laboratory services. We look forward to completing the development of automatic charge capture and billing services to further increase efficiencies for our customers and create a longer-term and sustainable relationship with them.”

About Medical Mime, Inc.

Medical Mime, is a dictation-based electronic health records (EHR) company and a wholly owned subsidiary of Rennova Health, Inc. Medical Mime offers a suite of highly-specialized software modules to create customized technology solutions. M2Select EHR is designed for facilities that specialize in substance abuse treatment and behavioral health; M2Pro EHR is for small-to-medium sized physician practices, and M2Speak is a dictation and transcription product for medical providers.

About Rennova Health, Inc.

Rennova Health provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

Rennova Health
Sebastien Sainsbury, 561-666-9818
ssainsbury@rennovahealth.com
or
Investors
LHA
Kim Golodetz, 212-838-3777
Kgolodetz@lhai.com
or
Bruce Voss, 310-691-7100
Bvoss@lhai.com

Source: Rennova Health Inc.

Released June 3, 2016